<DOC>
	<DOCNO>NCT02335801</DOCNO>
	<brief_summary>The objective study determine whether presence metabolic alteration anabolic deficiency patient chronic heart failure able identify subset patient poor outcome .</brief_summary>
	<brief_title>The TOSCA Registry : Hormonal Metabolic Deficiencies Chronic Heart Failure</brief_title>
	<detailed_description>Despite effectiveness neurohormonal model explain progression heart failure many insight provide development new therapy , increase clinical evidence suggest current model fail completely explain disease progression . Thus , neurohormonal model may necessary sufficient explain aspect disease progression fail heart . There evidence suggest heart failure metabolic imbalance characterize predominance catabolic status anabolic drive . Aim registry determine prevalence hormone/metabolic deficiency heart failure patient look possible association clinical variable . Moreover , enrol patient follow mean 2,5 year order collect outcome data include all-cause mortality , cardiovascular mortality , hospitalization . This multi-center observational study involve several Italian Department Cardiology , Endocrinology , Internal Medicine</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>patient either sex affect CHF , secondary ischemic idiopathic dilate cardiomyopathy left ventricle ejection fraction 40 % less severe liver disease serum creatinine level &gt; 2.5 mg/dl history active cancer life expectancy 1 year acute coronary syndrome previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>heart failure</keyword>
	<keyword>growth hormone</keyword>
	<keyword>testosterone</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>thyroid hormone</keyword>
	<keyword>survival</keyword>
</DOC>